Skip to main content

Advertisement

Log in

Opioid κ Receptors as a Molecular Target for the Creation of a New Generation of Analgesic Drugs

  • MOLECULAR BIOLOGY PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This review provides a brief description of the main structural and functional features of the κ opioid receptor, along with the properties of its agonists and the potential for using these in medicine. Of all the opioid receptor subtypes, κ receptors are the most attractive in terms of creating new drugs with a minimum of side effects. The opioid κ receptor is a member of the superfamily of metabotropic G-protein-coupled receptors. Opioid κ receptors are widely distributed in the CNS and at the periphery. They are involved in numerous physiological processes, including analgesia, regulation of neuroendocrine secretion, water balance, drinking and feeding behavior, autonomic functions, and the mechanisms of learning and memory. Data have been reported on the existence of three subtypes of κopioid receptor, though the molecular properties of only subtype 1 (ê1) have been studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. J. V. Aldrich and P. J. McLaughlin, AAPS J., 2, 312 – 322 (2009).

    Article  CAS  Google Scholar 

  2. M. R. Bruchas and C. Chavkin, J. Psychopharm., 2, 137 – 147 (2010).

    Article  CAS  Google Scholar 

  3. G. W. Pasternak, “The Opiate receptors,“ in: The Receptors (2011), p. 516.

  4. A. M. Trescot, S. Datta, M. Lee, et al., Pain Physician., 11, 133 – 153 (2008).

    Google Scholar 

  5. K. M. Wannemachera, A. Terskiy, S. Bian, et al., Brain Res., 3 – 26 (2008).

  6. T. Kenakin, Trends Pharmacol. Sci., 28(8), 407 – 415 (2007).

    Article  CAS  PubMed  Google Scholar 

  7. M. J. Marinissen and J. S. Gutkind, Trends Pharmacol. Sci., 22(7), 368 – 376 (2001).

    Article  CAS  PubMed  Google Scholar 

  8. B. E. Kane, B. Svensson, and D. M. Ferguson, AAPS J., 1, 126 – 137 (2006).

    Article  Google Scholar 

  9. L. Y. Liu-Chen, Life Sci., 75(5), 511 – 536 (2004).

    Article  CAS  PubMed  Google Scholar 

  10. A. W. Bruijnzeel, Brain Res. Rev., 1, 127 – 146 (2009).

    Article  CAS  Google Scholar 

  11. J. P. McLaughlin, M. Xu, K. Mackie, et al., J. Biol. Chem., 278(36), 34631 – 34640 (2003).

    Article  CAS  PubMed  Google Scholar 

  12. W. J. Carlezon, C. Beguin, A. T. Knoll, et al., J. Pharmacol. Ther., 3, 334 – 343 (2009).

    Article  CAS  Google Scholar 

  13. A. C. Gray, I. M. Coupar, and P. J. White, Life Sci., 7, 674 – 685 (2006).

    Article  CAS  Google Scholar 

  14. X. Y. Li, L. Sun, J. He, et al., Brain Res., 1326, 30 – 39 (2010).

    Article  CAS  PubMed  Google Scholar 

  15. B. A. S. Reyes, C. Chavkin, and E. J. Bockstaele, J. Comp. Neurol., 512(3), 419 – 431 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. A. I. Obara, I. R. Parkitna, M. Korostynski, et al., Pain., 141(3), 283 – 291 (2009).

    Article  CAS  PubMed  Google Scholar 

  17. Y. H. Wang, J. F. Sun, Y. M. Tao, et al., Acta Pharmacol. Sin., 31(9), 1065 – 1070 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. J. C. Lemos and C. Chavkin, “Kappa-opioid receptor function,“ in: Opiate Receptors, Pasternak G. W. (ed.) (2011), pp. 226 – 305.

  19. P. Rivière, Br. J. Pharmacol., 141(8), 1331 – 1334 (2004).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. C. Stein and L. J. Lang, Cur. Opin. Pharmacol., 9(1), 3 – 8 (2009).

    Article  CAS  Google Scholar 

  21. N. Q. Phan, T. Lotts, A. Antal, et al., Acta Derm. Venereol., 92(5), 555 – 560 (2012).

    Article  PubMed  Google Scholar 

  22. O. Pol, J. R. Palacio, and M. M. Puig, J. Pharmacol. Exp. Ther., 306(2), 455 – 462 (2003).

    Article  CAS  PubMed  Google Scholar 

  23. M. Ohsawa and J. Kamei, J. Pharmacol. Sci., 98(1), 25 – 32 (2005).

    Article  CAS  PubMed  Google Scholar 

  24. K. K. Rau, R. M. Caudle, B. Y. Cooper, et al., J. Chem. Neuroanat., 29(4), 255 – 264 (2005).

    Article  CAS  PubMed  Google Scholar 

  25. B. Kivell and T. E. Prisinzano, Psychopharm., 210(2), 109 – 119 (2010).

    Article  CAS  Google Scholar 

  26. Y. M. Tao, Q. L. Li, and C. F. Zhang, Eur. J. Pharmacol., 584(2 – 3), 306 – 311 (2008).

    Article  CAS  PubMed  Google Scholar 

  27. P. K. Peterson, G. Gekker, J. R. Lokensgard, et al., Biochem. Pharmacol., 61(9), 1145 – 1151 (2001).

    Article  CAS  PubMed  Google Scholar 

  28. S. Hu, W. S. Sheng, and R. B. Rock., J. Neuroimmune Pharmacol., 6(4), 528 – 539 (2011).

    Article  PubMed  Google Scholar 

  29. D. E. Rusovici, S. S. Negus, N. K. Mello, et al., Eur. J. Pharmacol., 485(1), 119 – 125 (2004).

    Article  CAS  PubMed  Google Scholar 

  30. E. R. Butelman and M. J. Kreek, Res. Devel. Opioid-Related Ligands, 13, 245 – 256 (2013).

    Article  CAS  Google Scholar 

  31. M. K. Greenwald and M. L. Stitzer, Drug Alcohol. Depend., 53(1), 17 – 30 (1998).

    Article  CAS  PubMed  Google Scholar 

  32. J. C. Gillis, P. Benfield, and K. L. Goa, Drugs, 50(1), 157 – 175 (1995).

    Article  CAS  PubMed  Google Scholar 

  33. S. P. Jaw, M. Makimura, B. Hoskins, et al., Eur. J. Pharmacol., 239(1 – 3), 133 – 140 (1993).

    Article  CAS  PubMed  Google Scholar 

  34. W. R. Martin, Pharmacol. Rev., 19(4), 463 – 521 (1967).

    CAS  PubMed  Google Scholar 

  35. P. Gharagozlou, E. Hashemi, T. M. DeLorey, et al., BMC Pharmacol., 6, 3 (2006).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. G. W. Pasternak and Y. Pan, Pharmacol. Rev., 65, 1257 – 1317 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. J. M. Bidlack, D. J. Cohen, J. P. McLaughlin, et al., J. Pharmacol. Exp. Ther., 302(1), 374 – 380 (2002).

    Article  CAS  PubMed  Google Scholar 

  38. K. M. Kumor, C. A. Haertzen, R. E. Johnson, et al., J. Pharmacol. Exp. Ther., 238(3), 960 – 968 (1986).

    CAS  PubMed  Google Scholar 

  39. J. Dortch-Carnes and D. E. Potter, CNS Drug Rev., 11(2), 195 – 212 (2005).

    Article  CAS  PubMed  Google Scholar 

  40. A. Coop and A. D. MacKerell, Am. J. Pharm. Educ., 66(2), 153 – 156 (2002).

    Google Scholar 

  41. S. Archer, S. D. Glick, and J. M. Bidlack, Neurochem. Res., 21(11), 1369 – 1373 (1996).

    Article  CAS  PubMed  Google Scholar 

  42. T. E. Prisinzano, K. Tidgewell, and W. W. Harding, AAPS J., 7(3), 592 – 599 (2005).

    Article  Google Scholar 

  43. J. Szmuszkovicz, Part II: 1991 – 1998. Progress in Drug Research., 53, 1 – 51 (1991).

  44. P. F. Von Voigtlander and R. A. Lewis, Progress in Neuropsychopharmacol. Biol. Psych., 6(4 – 6), 467 – 470 (1982).

    Article  Google Scholar 

  45. J. Kamei, Pulmonary Pharmacol., 9(5 – 6), 349 – 355 (1996).

    Article  CAS  Google Scholar 

  46. M. Hiramatsu and T. Kameyama, Methods Findings Experim. Clin. Pharmacol., 20(7), 595 – 599 (1998).

    Article  CAS  Google Scholar 

  47. H. Nagase and H. Fujii, Top. Cur. Chem., 299, 29 – 62 (2011).

    Article  CAS  Google Scholar 

  48. L. Zhou, K. M. Lovell, K. J. Frankowski, et al., J. Biol. Chem., 288(51), 36703 – 36716 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. P. F. Von Voigtlander and R. A. Lewis, J. Pharmacol. Exp. Ther., 246(1), 259 – 262 (1988).

    Google Scholar 

  50. S. G. Holtzman, Pharmacol. Biochem. Behav., 66(3), 517 – 522 (2000).

    Article  CAS  PubMed  Google Scholar 

  51. R. S. Zukin, M. Eghbali, D. Olive, et al., Proc. Natl. Acad. Sci. USA, 85(11), 4061 – 4065 (1988).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. C. P. France, F. Medzihradsky, and J. H. Woods, J. Pharmacol. Exp. Therap., 268(1), 47 – 58 (1994).

    CAS  Google Scholar 

  53. V. Kumar,M. A. Marella, L. Cortes-Burgos, et al., Bioorg. Med. Chem. Let., 10(22), 2567 – 2570 (2000).

    Article  CAS  Google Scholar 

  54. A. S. Yekkirala, J. Postdoctoral. Res., 4, 9 – 23 (2013).

    Google Scholar 

  55. A. La Regina, P. Petrillo, M. Sbacchi, et al., Life Sci., 42(3), 293 – 301 (1988).

    Article  PubMed  Google Scholar 

  56. W. Binder., H. Machelska, S. Mousa, et al., Anesth., 94(6), 1034 – 1044 (2001).

  57. P. M. Wall and C. Messier, Brain Res., 856(1 – 2), 259 – 280 (2000).

    Article  CAS  PubMed  Google Scholar 

  58. M. J. Millan, A. Czonkowski, A. Lipkowskiet, et al., J. Pharmacol. Exp. Therap., 251(1), 342 – 350 (1989).

    CAS  Google Scholar 

  59. R. W. Gear, O. Bogen, L. F. Ferrari, et al., Neuroscience, 257, 139 – 148 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. T. H. Privette and D. M. Terrian, Psychopharmacol., 118(4), 444 – 450 (1995).

    Article  CAS  Google Scholar 

  61. C. D. Soulard, S. Guerif, A. Payne, et al., J. Pharmacol. Exp. Ther., 279(3), 1379 – 1385 (1996).

    CAS  PubMed  Google Scholar 

  62. M. L. Wadenberg, CNS Drug. Rev., 9(2), 187 – 201 (2003).

    Article  CAS  PubMed  Google Scholar 

  63. M. Kunihara, M. Ohyama, M. Nakano, et al., Life Sci., 45, No. 13, 1191 – 1198 (1989).

    Article  CAS  PubMed  Google Scholar 

  64. Z. Stachura and Z. S. Herman, Pol. J. Pharmacol., 46(1 – 2), 37 – 41 (1994).

    CAS  PubMed  Google Scholar 

  65. M. K. Pugsley, E. J. Yu, and A. L. Goldin, Gen. Pharmacol., 34(6), 417 – 427 (2000).

    Article  CAS  PubMed  Google Scholar 

  66. J. McDonald and D. G. Lambert, Anaesthesia Intensive Care Med., 11, 505 – 509 (2013).

    Article  Google Scholar 

  67. C. R. McLaughlin, Q. Tao, and M. E. Abood, Drug Alcohol Depend., 38, 261 – 269 (1995).

    Article  CAS  PubMed  Google Scholar 

  68. A. Barber and R. Gottschlich, Expert Opin. Investig. Drugs, 6(10), 1351 – 1368 (1997).

    Article  CAS  PubMed  Google Scholar 

  69. S. L. Walsh, E. C. Strain, M. E. Abreu, et al., Psychopharmacol., 157(2), 151 – 162 (2001).

    Article  CAS  Google Scholar 

  70. P. R. Halfpenny, D. S. Horwell, J. Hughes, et al., J. Med. Chem., 33(1), 286 – 291 (1989).

    Article  Google Scholar 

  71. J. C. Hunter, G. E. Leighton, K. G. Meecham, et al., Br. J. Pharmacol., 101(1), 183 – 189.

  72. G. E. Leighton, M. A. Johnson, and K. G. Meecham, Br. J. Pharmacol., 72(3), 915 – 922 (1987).

    Article  Google Scholar 

  73. F. C. Tortella, Opioids: Epilepsy Neuroprotection, 104(2), 343 – 360 (1993).

    Article  Google Scholar 

  74. K. B. Mackay, K. Kusumoto, D. I. Graham, et al., Brain Res., 618(2), 213 – 219 (1993).

    Article  CAS  PubMed  Google Scholar 

  75. R. Dawkins, M. E. Lebsack, S. Wright, et al., J. Clin. Pharmacol., 31, 864 (1991).

    Google Scholar 

  76. P. A. Reece, A. J. Sedman, S. Rose, et al., J. Clin. Pharmacol., 34(11), 1126 – 1132 (1994).

    Article  CAS  PubMed  Google Scholar 

  77. G. F. Costello, R. James, and J. S. Shaw, J. Med. Chem., 34(1), 181 (1991).

    Article  CAS  PubMed  Google Scholar 

  78. J. J. Barlow, T. P. Blackburn, and G. F Costello, J. Med. Chem., 34(11), 3149 – 3158 (1991).

    Article  CAS  PubMed  Google Scholar 

  79. M. Narita, C. Kaneko, K. Miyoshi, et al., Neuropsychopharmacol., 31(4), 739 – 750 (2006).

    Article  CAS  Google Scholar 

  80. J. S. Shaw, J. A. Carroll, P. Alcock, et al., Br. J. Pharmacol., 96(4), 986 – 992 (1989).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. H. Kepta, V. Kayser, and G. Guilbaud, Eur. J. Pharmacol., 277(2 – 3), 275 (1995).

    Google Scholar 

  82. A. Barber, G. D. Bartoszyk, H. M. Bender, et al., Br. J. Pharmacol., 113(4), 1317 – 1327 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. N. L. Caram-Salas, G. Reyes-Garcna, G. D. Bartoszyk, et al., Eur. J. Pharmacol., 573(1 – 3), 75 – 83 (2007).

    Article  CAS  PubMed  Google Scholar 

  84. V. Vecchietti, A. Giordani, and G. Giardina, J. Med. Chem., 34(1), 397 – 403 (1991).

    Article  CAS  PubMed  Google Scholar 

  85. E. Zeynalov, M. Nemoto, P. D. Hurn, et al., J. Cereb. Blood. Flow. Metab., 26(3), 414 – 420 (2006).

    Article  CAS  PubMed  Google Scholar 

  86. S. Fang, H. Xu, J Lu, Y. Zhu, et al., Neurochem Res., 38(11), 2305 – 2312 (2013).

    Article  CAS  PubMed  Google Scholar 

  87. T. Y. Chen, T. Goyagi, T. J. Toung, et al., Stroke. J. Cerebral Circ., 35(5), 1180 – 1185 (2004).

    Article  CAS  Google Scholar 

  88. A. Naylor, D. B. Judd, J. E. Lloyd, et al., J. Med. Chem., 36(15), 2075 – 2083 (1993).

    Article  CAS  PubMed  Google Scholar 

  89. B. S. Meldrum, Brain Pathol., 3(4), 405 – 412 (1993).

    Article  CAS  PubMed  Google Scholar 

  90. B. S. Meldrum, Neurology, 44(11), Supplement 8, 14 – 23 (1994).

  91. P. J. Birch, H. Rogers, and A. G. Hayes, Br. J. Pharmacol., 103(3), 1819 – 1823 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. A. I. Faden and S. Salzman, Trends Pharmacol. Sci., 13(1), 29 – 35, (1992).

    Article  CAS  PubMed  Google Scholar 

  93. J. F. Herrero and P. M. Headley, Br. J. Pharmacol., 110(1), 303 – 309 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. J. Ho, A. J. Mannes, R. Dubner, and R. M. Caudle, J. Pharmacol. Exp. Ther., 281(1), 136 – 141 (1997).

    CAS  PubMed  Google Scholar 

  95. M. C. Ko and S. M. Husbands, J. Pharmacol. Exp. Ther., 328(1), 193 – 200 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. J. J. Wagner, R. M. Caudle, and C. Chavkin, J. Neurosci., 12(1), 132 – 141 (1992).

    CAS  PubMed  Google Scholar 

  97. R. M. Caudle, C. Chavkin, and R. Dubner, J. Neurosci., 14(9), 5580 – 5589 (1994).

    CAS  PubMed  Google Scholar 

  98. Y. Tsukahara-Ohsumi, F. Tsuji, M. Niwa, et al., Eur. J. Pharmacol., 647(1 – 3), 62 – 67 (2010).

    Article  CAS  PubMed  Google Scholar 

  99. Y. Tsukahara-Ohsumi, F. Tsuji, M. Niwa, et al., Eur. J. Pharmacol., 671(1 – 3), 53 – 60 (2011).

    Article  CAS  PubMed  Google Scholar 

  100. H. Nagase, J. Hayakawa, K. Kawamura, et al., Chem. Pharm. Bul., 46(2), 66 – 369 (1998).

    Article  Google Scholar 

  101. H. Kumagai, T. Ebata, K. Takamori, et al., Am. J. Nephrol., 36(2), 175 – 183 (2012).

    Article  CAS  PubMed  Google Scholar 

  102. B. Wikstrtsm, R. Gellert, S. D. Ladefoged, et al., J. Am. Soc. Nephrol., 16(12), 3742 – 3747 (2005).

    Article  CAS  Google Scholar 

  103. K. Nakao, K. Ikeda, T. Kurokawa, et al., Nihon Shinkei Seishin Yakurigaku Zasshi., 28(2), 75 – 85 (2008).

    CAS  PubMed  Google Scholar 

  104. T. Endoh, H. Matsuura, A. Tajima, et al., Life Sci., 65(16), 1685 – 1694 (1999).

    Article  CAS  PubMed  Google Scholar 

  105. T. Endoh, A. Tajima, T. Suzuki, et al., Eur. J. Pharmacol., 387(2), 133 – 140 (2000).

    Article  CAS  PubMed  Google Scholar 

  106. H. Kumagai, T. Ebata, K. Takamori, et al., Nephrol. Dial. Transplant., 25(4), 1251 – 1257 (2010).

    Article  CAS  PubMed  Google Scholar 

  107. H. Kumagai, K. Yamamoto, T. Kushiyama, et al., Kidney Dialysis, 70(4), 651 – 657 (2011).

    Google Scholar 

  108. S. Inui, Y. Shirakawa, and S. Itami, J. Dermatol., 39(10), 1253 (2011).

    Google Scholar 

  109. H. Ichinose, Eur. J. Pharmacol., 606(1 – 3), 102 – 108 (2009).

    PubMed  Google Scholar 

  110. K. Yamamizu, S. Furuta, S. Katayama, et al., Blood., 118(3), 775 – 785 (2011).

    Article  CAS  PubMed  Google Scholar 

  111. Thomson Reuters Integrity: Official search site for the “Thomson Reuters Integrity“ system [electronic resource]. URL: http://integrity.thomson-pharma.com (accessed on April 22, 2011).

  112. M. Delvaux and J. Frexinos, Expert. Opin. Investig. Drugs, 10(1), 97 – 110 (2001).

    Article  CAS  PubMed  Google Scholar 

  113. F. De Ponti, Front Pharmacol., 4, 7 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  114. M. J. Callahan, J. Clin. Gastroenterol., 35(1), 58 – 67 (2002).

    Article  Google Scholar 

  115. B. Le Bourdonnec, C. W. Ajello, P. R. Seida, et al., Bioorg. Med. Chem. Let., 15(10), 2647 – 2652 (2005).

    Article  CAS  Google Scholar 

  116. J. C. Eisenach, R. Carpenter, and R. Curry, Pain., 101(1 – 2), 89 – 95 (2003).

    Article  CAS  PubMed  Google Scholar 

  117. M. Camilleri, Neurogastroenterol. Motil., 20(9), 971 – 979 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. A. W. Mangel and G. A. Hicks, Clin. Exp. Gastroenterol., 5, 1 – 10 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. N. J. Talley, R. S. Choung, M. Camilleri, et al., Aliment. Pharmacol., 27(11), 1122 – 1131 (2008).

    Article  CAS  Google Scholar 

  120. A. W. Mangel and V. S. Williams, Expert Opin. Investig. Drugs, 19(10), 1257 – 1264 (2010).

    Article  CAS  PubMed  Google Scholar 

  121. G. X. Xie, F. Meng F, A. Mansour, et al., Proc. Natl. Acad. Sci. USA,, 91, 3779 – 3783 (1994).

  122. A. T. Knoll and J. Carlezon, Brain Res., 1314, 56 – 73 (2010).

    Article  CAS  PubMed  Google Scholar 

  123. M. Connor and I. Kitchen, Br. J. Pharmacol., 147(4), 349 – 350 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. T. Oshima, J. Pharmacol. Sci., 98(1), 25(2005).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 1, pp. 3-11 – 10, January, 2016.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grechko, O.Y., Spasov, A.A. & Shtareva, D.M. Opioid κ Receptors as a Molecular Target for the Creation of a New Generation of Analgesic Drugs. Pharm Chem J 50, 1–9 (2016). https://doi.org/10.1007/s11094-016-1388-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-016-1388-z

Keywords

Navigation